IBB vs XLB
iShares Biotechnology ETF vs Materials Select Sector SPDR
- • XLB has the lower expense ratio at 0.08% vs 0.44% for IBB.
- • XLB pays a higher dividend yield (1.67%).
Side-by-side metrics
| Metric | IBB | XLB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.08% |
Dividend yield Trailing 12-month yield. | 0.22% | 1.67% |
AUM Assets under management — bigger funds are typically more liquid. | $9.09B | $8.17B |
YTD return | 16.44% | 11.51% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.69 | 0.82 |
P/E ratio | 24.89 | 25.93 |
Last price | $197.34 | $50.26 |
Inception | — | — |
Issuer | iShares | State Street |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
XLB top holdings
| LIN | Linde PLC | 14.04% |
| NEM | Newmont Corp | 5.84% |
| FCX | Freeport-McMoRan Inc | 5.29% |
| CTVA | Corteva Inc | 4.95% |
| SHW | Sherwin-Williams Co | 4.93% |
| ECL | Ecolab Inc | 4.72% |
| VMC | Vulcan Materials Co | 4.71% |
| CRH | CRH PLC | 4.66% |
| APD | Air Products and Chemicals Inc | 4.62% |
| MLM | Martin Marietta Materials Inc | 4.54% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About XLB
XLB (Materials Select Sector SPDR) is S&P 500 materials sector. Managed by State Street, the fund carries $8.2B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.67%. Its largest holding is Linde PLC (LIN), which represents 14.0% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 15.4%.